Successful Management of Tardive Dyskinesia with Quetiapine and Clonazepam in a Patient of Schizophrenia with Type 2 Diabetes Mellitus

다국어 초록 (Multilingual Abstract)

Tardive dyskinesia is one of the most significant side effects of antipsychotic medications. Antipsychotic treated schizophrenia patients with diabetes mellitus are more likely to develop tardive dyskinesia than those without diabetes. Clozapine is probably best supported for management of tardive dyskinesia. But clozapine has been strongly linked to hyperglycaemia and impaired glucose tolerance, so it is not preferred in patients with diabetes mellitus. We present a case of 35-year-old male with a diagnosis of schizophrenia and type 2 diabetes mellitus with tardive dyskinesia, who was successfully treated with quetiapine and clonazepam.

참고문헌 (Reference)

1 Ganzini L, "The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled study" 48 : 259-263, 1991

2 Kay SR, "The positive and negative syndrome scale (PANSS) for schizophrenia" 13 : 261-276, 1987

3 Llorca PM, "Tardive dyskinesias and antipsychotics: a review" 17 : 129-138, 2002

4 Duncan D, "Tardive dyskinesia: how is it prevented and treated?" 21 : 422-425, 1997

5 Ascher-Svanum H, "Tardive dyskinesia and the 3-year course of schizophrenia: results from a large, prospective, naturalistic study" 69 : 1580-1588, 2008

6 Ganzini L, "Tardive dyskinesia and diabetes mellitus" 28 : 281-286, 1992

7 Fenton WS, "Risk factors for spontaneous dyskinesia in schizophrenia" 51 : 643-650, 1994

8 Vesely C, "Remission of severe tardive dyskinesia in a schizophrenic patient treated with the atypical antipsychotic substance quetiapine" 15 : 57-60, 2000

9 Farah A, "Reduction of tardive dyskinesia with quetiapine" 47 : 309-310, 2001

10 Alptekin K, "Quetiapine-induced improvement of tardive dyskinesia in three patients with schizophrenia" 17 : 263-264, 2002

11 Mukherjee S, "Possible association between tardive dyskinesia and altered carbohydrate metabolism" 42 : 205-, 1985

12 Mukherjee S, "Persistent tardive dyskinesia and neuroleptic effects on glucose tolerance" 29 : 17-27, 1989

13 Kinon BJ, "Olanzapine treatment for tardive dyskinesia inschizophrenia patients: a prospective clinical trial with patients randomized to blinded dose reduction periods" 28 : 985-996, 2004

14 Mukherjee S, "Neuroleptic-induced movement disorders" Cambridge University Press 1997

15 Schultz SK, "Impaired glucose tolerance and abnormal movements in patients with schizophrenia" 156 : 640-642, 1999

16 Tarsy D, "Epidemiology of tardive dyskinesia:is risk declining with modern antipsychotics?" 21 : 589-598, 2006

17 Lévy E, "Diabetes, tardive dyskinesia, parkinsonism, and akathisia in schizophrenia:a retrospective study applying 1998 diabetes health care guidelines to antipsychotic use" 49 : 398-402, 2004

18 Woerner MG, "Diabetes and development of tardive dyskinesia" 150 : 966-968, 1993

19 Bhoopathi PS, "Benzodiazepines for neuroleptic-induced tardive dyskinesia" (3) : CD000205-, 2006

20 Sernyak MJ, "Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia" 159 : 561-566, 2002

21 Lane RD, "Assessment of tardive dyskinesia using the Abnormal Involuntary Movement Scale" 173 : 353-357, 1985

22 Emsley R, "A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia" 65 : 696-701, 2004